Using enrichment pathway analysis, protein-protein interaction analysis, immunophenotype and pan-cancer analysis, Zheng et al. found that TSPAN4 expression was associated with cancer, especially in glioblastoma multiforme and low-grade gliomas (Zheng et al., 2022). The gene discussed is TSPAN4; the disease is central nervous system cancer.